"We welcome today's European Commission decision reflecting the first authorization of a protein-based COVID-19 vaccine for the people of the E.U.," said Stanley C. Erck, Novavax's CEO.
[...]
The European Commission has already signed a contract with Novavax for the advance purchase of 200 million doses of its vaccine once it has been approved by the EMA. [...] Indonesia and the Philippines have already approved Novavax's jab, while Japan has agreed to buy 150 million doses. Novavax says it has also filed for approval in Britain, India, Australia, New Zealand, Canada, and with the World Health Organization.